PDB20 COST-EFFECTIVENESS OF DULOXETINE VERSUS ROUTINE TREATMENT FOR PAINFUL DIABETIC NEUROPATHY IN A RANDOMIZED TRIAL FROM A SOCIETAL PROSPECTIVE
Abstract
Authors
EQ Wu HG Birnbaum MN Mareva TK Le A Rosen R Robinson P Corey-Lisle